Ambisome and Meningitis - a phase IV clinical study of FDA data

Summary:

Meningitis is reported as a side effect among people who take Ambisome (amphotericin b), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Prograf, and have Cytokine release syndrome.

The phase IV clinical study analyzes which people have Meningitis when taking Ambisome. It is created by eHealthMe based on reports of 7,928 people who have side effects when taking Ambisome from the FDA, and is updated regularly.

What is Ambisome?

Ambisome has active ingredients of amphotericin b. eHealthMe is studying from 7,934 Ambisome users. Check the latest studies of Ambisome.

What is Meningitis?

Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges) is found to be associated with 651 drugs and 882 conditions by eHealthMe. Check the latest studies of Meningitis.

On Jul, 25, 2026

7,928 people reported to have side effects when taking Ambisome.
Among them, 21 people (0.26%) have Meningitis.

Among these 21 people:

How long have people been on Ambisome when they have Meningitis? *

What is the gender of people who have Meningitis when taking Ambisome? *

female: 23.81 %
male: 76.19 %

What is the age of people who have Meningitis when taking Ambisome? *

What are other drugs people take besides Ambisome? *

What are other side effects people have besides Meningitis? *

Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 7 people, 33.33%
Drug Ineffective: 6 people, 28.57%
General Physical Health Deterioration (weak health status): 6 people, 28.57%
Renal Impairment (severely reduced kidney function): 5 people, 23.81%
Headache (pain in head): 5 people, 23.81%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 4 people, 19.05%
Fever: 4 people, 19.05%
Hepatic Enzyme Increased: 3 people, 14.29%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 14.29%
Coccidioidomycosis (serious disease of the lungs and other tissues, caused by the fungus coccidioides immitis): 3 people, 14.29%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 3 people, 14.29%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 3 people, 14.29%
Systemic Candida (whole body fungal infection): 2 people, 9.52%
Hypokalemia (low potassium): 2 people, 9.52%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 9.52%
Herpes Simplex (herpes simplex is a common viral infection): 2 people, 9.52%
High Blood Pressure: 2 people, 9.52%
Sedation: 2 people, 9.52%
Hypersensitivity: 2 people, 9.52%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Ambisome and have Meningitis?

- Check whether Meningitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ambisome:

Ambisome (7,934 reports)

Meningitis treatments and more:

Meningitis (9,443 reports)

Browse all side effects of Ambisome:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Meningitis:

Meningitis (651 drugs)

Browse all the conditions that are associated with Meningitis:

Meningitis (882 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amphotericin b (the active ingredients of Ambisome) and Ambisome (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.